CC
CC
NYSE · Chemicals

Chemours Co/The

$23.04
+0.63 (+2.81%)
As of May 9, 1:26 AM ET ·
Financial Highlights (FY 2026)
Revenue
5.65B
Net Income
-375,800,760
Gross Margin
15.5%
Profit Margin
-6.7%
Rev Growth
-5.1%
D/E Ratio
16.56
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 15.5% 15.5% 63.7% 63.7%
Operating Margin -1.2% -1.1% 17.2% 16.6%
Profit Margin -6.7% -6.3% 14.1% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.65B 5.96B 1.47B 1.14B
Gross Profit 878.14M 925.23M 935.67M 729.26M
Operating Income -67,288,259 -63,807,220 252.18M 189.87M
Net Income -375,800,760 -356,359,376 207.35M 138.00M
Gross Margin 15.5% 15.5% 63.7% 63.7%
Operating Margin -1.2% -1.1% 17.2% 16.6%
Profit Margin -6.7% -6.3% 14.1% 12.1%
Rev Growth -5.1% -5.1% +3.4% -3.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.59B 1.59B 238.65M 224.84M
Total Equity 95.93M 95.93M 1.62B 1.46B
D/E Ratio 16.56 16.56 0.15 0.15
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 299.86M 300.14M 357.73M 261.35M
Free Cash Flow 156.58M 99.38M